Free Trial
LON:4BB

4basebio (4BB) Share Price, News & Analysis

4basebio logo
GBX 1,000 +15.00 (+1.52%)
As of 07/18/2025 12:43 PM Eastern

About 4basebio Stock (LON:4BB)

Key Stats

Today's Range
970
1,000
50-Day Range
940
1,150
52-Week Range
940
1,550
Volume
2,510 shs
Average Volume
1,034 shs
Market Capitalization
£128.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 1,600
Consensus Rating
Buy

Company Overview

Receive 4BB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 4basebio and its competitors with MarketBeat's FREE daily newsletter.

4BB Stock News Headlines

4BASEBIO UK SOCIETAS (4BB) - Investing.com UK
4basebio Plc - Director Appointment, Board Change
The big winner of Crypto week?
It’s Crypto Week at the White House — and the sector is moving from fringe to full-scale adoption. With Bitcoin hitting $123,000 and giants like BlackRock and Fidelity pouring in, one expert believes a lesser-known coin could soon be vaulted to the top — possibly even landing in the government’s digital reserve.
See More Headlines

4BB Stock Analysis - Frequently Asked Questions

4basebio's stock was trading at GBX 1,210 at the beginning of 2025. Since then, 4BB stock has decreased by 17.4% and is now trading at GBX 1,000.

4basebio PLC (LON:4BB) announced its quarterly earnings results on Tuesday, May, 27th. The company reported ($0.94) earnings per share (EPS) for the quarter.

Shares of 4BB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that 4basebio investors own include B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC), IQE (IQE) and Omega Diagnostics Group (ODX).

Company Calendar

Last Earnings
5/27/2025
Today
7/20/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:4BB
CIK
N/A
Fax
N/A
Employees
101
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 1,600
Low Price Target
GBX 1,600
Potential Upside/Downside
+60.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX (0.78)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£9.84 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-231.29%
Return on Assets
-54.30%

Debt

Debt-to-Equity Ratio
201.47
Current Ratio
2.73
Quick Ratio
3.52

Sales & Book Value

Annual Sales
£311 thousand
Price / Sales
411.90
Cash Flow
GBX 62.19 per share
Price / Cash Flow
16.08
Book Value
GBX (41) per share
Price / Book
-24.39

Miscellaneous

Outstanding Shares
12,810,000
Free Float
N/A
Market Cap
£128.10 million
Optionable
Not Optionable
Beta
1.09
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (LON:4BB) was last updated on 7/20/2025 by MarketBeat.com Staff
From Our Partners